The Immune Response to Influenza Vaccinations in Elderly Individuals
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Trials Related to Influenza
Related studies linked through entity extraction aliases.
Ellume.Lab Flu A+B Test and iTreat Flu A+B Flu Test Performance Versus Viral Culture and Reverse Transcriptase Polymerase Chain Reaction.
- Status
- COMPLETED
- Phase
- NA
Vaccination Education Through Pharmacists and Senior Centers (VEPSC)
- Status
- COMPLETED
- Phase
- NA
Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Patients ≥65 Years
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Single-ascending-dose Study of the Safety and Immunogenicity of NasoVAX
- Status
- COMPLETED
- Phase
- PHASE2
Biomarkers for the Prognosis of Influenza in Children
- Status
- COMPLETED
- Phase
- NA
Influenza HA Ferritin Vaccine, Alone or in Prime-Boost Regimens With an Influenza DNA Vaccine in Healthy Adults
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy of FLU-v in an H1N1 Influenza Human Challenge Model
- Status
- COMPLETED
- Phase
- PHASE2
Immune Response Following Seasonal Influenza Vaccination
- Status
- COMPLETED
- Phase
- PHASE4
Study to Evaluate the Safety of 1 New 6:2 Influenza Virus Reassortant in Adults for the 2017-2018 Season
- Status
- COMPLETED
- Phase
- PHASE4
Evaluate the Shedding and Immunogencity of Different Formulations of FluMist in Children 24 to <48 Months of Age
- Status
- COMPLETED
- Phase
- PHASE4
High Dose vs. Standard Influenza Vaccine in Adult SOT
- Status
- COMPLETED
- Phase
- PHASE3
Assessment of Viral Shedding in Children Previously in Receipt of Multiple Doses of Live Attenuated Influenza Vaccine (LAIV) Compared to Influenza Vaccine-naïve Controls
- Status
- COMPLETED
- Phase
- PHASE4
Live Attenuated Influenza Vaccine (LAIV) Versus Trivalent Inactivated Influenza Vaccine in Healthy Adults 18-49 Years
- Status
- COMPLETED
- Phase
- PHASE4
Genetic and Environmental Factors in the Response to Influenza Vaccination
- Status
- COMPLETED
- Phase
- PHASE1
Safety, Tolerability, and Immunogenicity of VAL-506440 in Healthy Adult Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Comparison of Three Licensed Influenza Vaccines
- Status
- COMPLETED
- Phase
- PHASE4
Safety and Efficacy of Concurrent Administration of Influenza Vaccine in Patients Undergoing Anti-PD-1 Immunotherapy (Nivolumab, Pembrolizumab)
- Status
- COMPLETED
- Phase
- N/A
Two Doses of Multimeric-001 (M-001) Followed by Influenza Vaccine
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Performance of the Diassess Influenza A and B Test
- Status
- COMPLETED
- Phase
- NA